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ABSTRAK 
Penggunaan ulang alat suntik sekali pakai rusak merupakan pilihan dalam mencapai 
suntikan aman. Salah satunya adalah unijectTM berisi vaksin Hep B atau TT yang dapat 
disimpan pada suhu kamar selama 1-2 bulan. Penggunaannya merupakan alternutif untuk 
meningkutkan cakupan dun mencegah penyakit yang dapat ditularkan melalui jarum suntik, 
terutama di daerah terpencil. 
Dalam pencapaian Eliminasi Tetanus Neonatorum di Indonesia, imunisasi TT pada 
siswa SD dilakukan pada bulan imunisasi anak sekolah (BIAS), setiap bulan November mulai 
tahun 1998. Penelitian yang bertujuan untuk menilai pemahaman materi latihan dun praktek 
penggunaan unijectTM pada 1788 orang siswa SD kelas 2-6 pada program BIAS, serta 
nzengetahui penerimaan vaksinator dun siswa telah dilakukan di 3 kubupaten di Yogyakarta. 
Hasil penelitian menunjukkan bahwa materi pelatihan telah dapat dimengerti oleh 
supervisor dun vaksinator. Kemudahan mengaktivasi unijectTM adalah 97,76% dun vabinator 
yang merasa tidak mengalami kesulitan sebanyak 97,87%. Hanya 1,94% yang belum dapat 
menekan reservoir. secara benar sehingga dosis vaksin menjadi kurang. Pembuangan alat 
suntik bekas 99,89% telah dilakukan dengan benar. Jumlah Uniject yang rusak saat akan 
digunakan sebanyak 24 buah (1,35%), sebagian besar karena jarum belum teraktivasi 
dengan baik sehingga timbul kebocoran atau jarum terlepas. 
Pada pelatihan yang perlu diperhatikun adalah: Cara menekan reservoir dengan 
benar agar diperoleh dosis yang tepat dun cara menyuntik dengan memperhatikan posisi 
unijectTM dun kedalaman jarum. Hasil pemantauan menunjukkan tidak ditemui adanya 
reaksi samping akibat imunisasi TT. 
A survey in developing countries changing the syringe does not solve the 
ions are revealed that 30 to 50% of inject' problem and still poses significant risks for 
administered in an unsterile condition'). transmission of infectious blood-borne 
Disposable syringes are used more than diseases such as Hepatitis B, Hepatitis C, 
once with improper sterilization and HIV~). This practice primarily resulted 
procedures. Changing needles without from budget limitation and insufficient 
* Pusat Penelitian dan Pengembangan Pemberantasan Penyakit, Badan Litbang Kesehatan, Jakarta 
** Subdit Imunisasi, Ditjen P2M & PL, Jakarta. 
Bul. Penelit. Kesehat. 28 (3&4) 2000 
Assessment of uniject training . . . . . . . . . .. Muljati Prijanto et al 
comprehension of, or adherence to safe 
injection procedures and requirements. 
Autodestruct single use injection device 
therefore is one the choice to achieve 
safe injection in mass immunization 
campaigns. 
During the last decade there have 
been a number of developments for 
autodestruct single use injection devices, 
one of which is uniJectTM. This device 
was developed by Program for Appropriate 
Technology in Health (PATH) with 
funding from the United States Agency for 
International Development (USAID). In 
1996 the UniJectTM technology was 
licensed to Becton Dickinson and 
Company (BD) who is currently 
manufacturing and distributing the device 
globally. As with stanhard autodestruct 
syringes, the uniJectTM device addresses 
the issue of assured sterility, and since the 
UniJectTM device is prefilled with a single 
dose of vaccine, it has additional 
advantages of minimizing the steps 
required for dose delivery, maximizing 
dose accuracy and reducing vaccine 
wastage3). 
The availability of heat stable 
vaccines such as tetanus toxoid (TT) and 
Hepatitis B (HB)~) make the use of 
UniJectTM devices an option for improving 
the immunization coverage. Prefilled 
uniJectTM devices with TT and HB 
vaccines can be kept at ambient 
temperature for direct access and on-time 
immunization by root level service 
providers in villages without requiring the 
cold chain for up to 1-2 months before a 
resupply is needed. Between 1995 and 
1996, 10,000 U n i ~ e c t s ~ ~  were used in this 
manner by midwives to deliver TT and HB 
vaccines to mothers and infants 
respectively in their homes on the islands 
of Lombok and ~ a l i ~ , ~ ) .  
In 1998 the government introduced 
an annual student immunization month 
(BIAS) for delivering TT to all grade 11-VI 
primary school students, with the goal that 
each student will have received TT 
vaccination 5 times by the time they finish 
primary school. There is interest in using 
UniJectTM in this program as one of 
the alternative to increase the TT 
immunization coverage into remote areas. 
Additionally in 1999, there will be a 
program to start using uniJectTM with HB 
in mass immunization campaign. Because 
of its unique properties supplementary 
training for the uniJectTM procedure usage 
is deemed necessary for the vaccinators. To 
assess whether the current training 
materials will result in proper 
comprehension and practice, an assessment 
of training is performed. 
The aims of the study were: To 
evaluate the training result on the 
comprehension and practice of using 
UniJectTM; to evaluate the performance of 
UniJectTM with TT on students of grade I1 
to VI in BIAS program and to assess the 
acceptability of uniJectTM among the 
vaccinators and students. 
MATERIALS AND METHODS 
UniJectTM is a single-use plastic 
injection device prefilled with a single dose 
of vaccine or medicament enclosed in a 
sealed blister with a permanent needle 
attached. The device cannot be reused or 
refilled. Injection is administered by 
squeezing the reservoir to get the dose out 
leaving air and a small amount of vaccine 
inside the blister. 
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UniJectW syringe 
Neck Blister 
Filling of '2600 uniJectTM with 
tetanus toxoid was conducted in the 
Communicable Disease Laboratory in 
Jakarta. Sterility test was conducted 
alongside during the filling according to 
the WHO recommendation and the result 
formed the basis for releasing the vaccine 
for use. The vaccine-filled uniJectsTM 
were kept at 2-8' C through out the storage 
period except on the day of immunization 
when they were transported to the schools. 
After the study leftover ~ n i ~ e c t s ~ ~  were 
discarded into a special sharps disposal box 
made of thick cardboard. 
The study was conducted in 3 
districts in Yogyakarta: Gunung Kidul, 
Bantu1 and Sleman based on the 
availability of good health infrastructures 
and good cooperation from the community. 
The activity consisted of training on the 
use of uniJectTM followed by TT 
immunization. All 24 vaccinators attended 
the trainin in which they were introduced 
to UniJecjM, and trained on its use. In the 
practice session each vaccinator used 
uniJectTM to inject an orange each 10 
times. Supervisors of vaccinators were 
also trained on conducting observation, 
interview, and filling of a checklist form. 
Following the training, immuni- 
zation was conducted for 6 consecutive 
days at the 3 above mentioned districts. 
Out of each district 2 health centers were 
selected and out of each health center 2 
schools were requested to participate in the 
study. The target sample was 1788 
students from grade I1 to VI. Details are 
described below: 
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Tabel 1. The location of study and the number of students. 
Following each immunization day 
the vaccinator's comments and impression 
on uniJectTM was discussed and recorded 
in a checklist form together with the 
supervisors, observation throughout the 
day's activity. 
RESULTS AND DISCUSSION 
NUMBER OF 
STUDENTS 
113 
136 
125 
127 
169 
154 
161 
16 1 
, , 226 
103 
152 
16 1 
The immunization result is 
summarized in Table 2. The average time 
required to administer an injection using 
uniJectTM starting from preparation to 
finish was relatively short that is 44.77 
seconds. 
SCHOOL 
Piyaman I 
Piyaman IV 
Madrasah Negeri 
Gubug Rubuh 
Manding 
Sabdodadi I1 
Donotirto 
Sembungan 
Klegung I 
Klegung I1 
Turi I 
Turi I11 
The supervisors' observation during the 
activity is summarized in Table 3. The 
activity is divided into 3 stages: 
HEALTHCENTER 
Wonosari 2 
Playen 2 
Bantul 2 
Kasihan I 
Tempel 
Turi 
NO. 
1. 
2. 
3. 
1. Preparation or activation of uniJectTM: 
opening the foil pouch, activation, ' 
checking the connection between the 
uniJectTM neck and cap and inspecting 
for any leakage. The study shows that 
97.76% of the vaccinators found 
activation to be easy, and only 2.24% 
had trouble with this step. 
2. Injection: squeezing the vaccine- 
containing reservoir. Most of the 
vaccinators (97.87%) could also 
perform the injection correctly and only 
1.94% did not squeeze the reservoir 
properly such that less vaccine was 
delivered. 
3. Disposal: not recapping the uniJectTM 
after use, and proper disposal procedure. 
The study shows that most of the 
vaccinators (99.89%), disposed of 
uniJectTM correctly. 
DISTRICT 
Gunung Kidul 
Bantul 
Sleman 
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Table 2. Average Time Required by 24 Vaccinators to Perform TT Immunization using 
~ n i ~ e c t ~ ~  on Primary School Students at 3 Districts in Yogakarta. 
Table 3. Details on the Use of ~ n i ~ e c t ~ ~  during TT Immunization on 1788 Primary 
School Skudents at 3 Districts in Yogyakarta 
Location 
Gunung Kidul 
Bantu1 
Sleman 
Total 
These results show that all of the 
activities required in piforming an 
injection with UniJect could be 
performed properly with only very few 
Average of 
Students 
501 
642 
645 
1788 
Average of Vaccinators 
8 
8 
8 
24 
NO. 
mistakes (92.96%). It can therefore be 
concluded that there was sufficient 
comprehension of the training 
material. 
7 
Ave. Time per 
Injection (seconds) 
41.68 
48.32 
43.63 
44.77 
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ACTIVITIES 
Preparation 
Number of 
Students 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
% True 
The foil pouch opened on the first pull 
The device was easy to activate 
The blister was not pressed during activation 
The vaccinator inspected the connection between the neck 
and the cap 
Cap was easy to remove 
Vaccinator did not stick himherself with the needle 
Vaccine leaked upon cap removal (lose a few drops) 
1 
Injection 
1788 
1747 
1783 
1782 
1782 
1782 
1782 
100 
97.76 
99.72 
99.83 
99.66 
99.66 
99.66 
8. 
9. 
10. 
1 1. 
12. 
1788 
1784 
1735 
1753 
1750 
The injection site was cleaned prior to injection 
Injection was administered at the center of the injection site 
The vaccinators had no difficulty performing the injection 
Blister was squeezed/pressed correctly (able to get out the 
whole dose) 
No difficulty experienced with uniJectTM 
100 
99.78 
92.96 
98.04 
97.87 
Disposal 
100 
99.89 
1788 
1786 
13. 
14. 
The needle was not recapped 
Used uniJectsTM were disposed of properly 
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Table 4. Number of Defective uniJectTM and Possible Causes 
Number of UniJectTM used for the study: 1788 
Out of the 1788 uniJectTM used resulted from incomplete activation 
for immunization, 24 of them (1.35%) that gave rise to leakage or 
were found defective as detailed in detachment of the needle. This could 
Table 5. Further examination overseas be a point of consideration in future use 
concluded that most- of the problem of uniJectTM. 
No. 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
Table 5. Acceptability of uniJectTM Among 24 Vaccinators during the Study in 
Yogyakarta 
Number 
7 
2 
7 
3 
1 
1 
1 
2 
24 
Explanation 
Vaccine drippedlleaked through the UniJectTM port during 
injection 
Vaccine leaked through the sealed top part of UniJectTM 
Vaccine leaked around the needle hub 
Needle was detached before activation 
Label came off 
Foil pouch was no longer sealed 
Dull needle (unable to penetrate skin) 
UniJectTM leaked before use (no specific explanation) 
Total 
YO 
0.39 
0.1 1 
0.39 
0.17 
0.06 
0.06 
0.06 
0.1 1 
1.35 
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No. 
1 .  
2. 
3. 
4. 
5. 
6. 
Number of 
Responses 
19 
4 
1 
5 
19 
2 4 
19 
5 
24 
2 1 
2 
1 
24 
Explanation 
Problem in using uniJectTM: 
- no problem 
- some problem: - difficult to activate 
- vaccine leaked from the needle hub 
Defects found in UniJectTM: 
- no defects found 
- yes, found some defects or label came off 
Use of UniJectTM compared with reusable injection devices: 
- easier to use 
- practical and already sterile 
- no comments 
Use of ~ n i ~ e c t ~  compared with disposable injection devices: 
- easier to use 
Use of UniJectTM compared with T-PAD: 
- easier to use 
- the same 
- more difficult 
Opinion about UniJectTM compared with other injection 
devices: 
UniJectTM is more practical and easier to use 
% 
79.16 
16.67 
4.17 
20.83 
79.17 
100 
79.16 
2.10 
100 
87.50 
8.33 
4.16 
100 
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All of the vaccinators and students easily transported because of the less rigid 
(100%) had a favorable impression cold chain requirement, while the 
toward uniJectTM and accepted the uniJectTM's small size created less fear and 
device. The vaccinators consider therefore less perceived pain among the 
uniJectTM as practical, sterile, and more students. 
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% 
4.16 
25.0 
4.16 
4.16 
4.16 
8.60 
50.0 
83.33 
16.67 
100 
91.66 
8.33 
100 
100 
100 
75.0 
8.33 
16.67 
96.0 
4.0 
91.67 
8.33 
45.8 
8.33 
20.8 
25.0 
Number of 
Responses 
1 
6 
1 
1 
1 
2 
12 
20 
4 
24 
22 
2 
24 
24 
24 
18 
2 
- 4 
23 
1 
22 
2 
11 
2 
5 
6 
No. 
7. 
8. 
9 .  
10. 
1 1. 
12. 
13. 
14. 
15. 
16. 
17. 
Explanation 
Opinion about dislike the most of uniJectTM 
- is activated too soon 
- difficult to activate 
- neck too short 
- needle too long 
- need to have a lot in stock 
- a little problem 
- no problem 
Injection device of choice: uniJectTM with reason: 
- practical 
- no reason 
Frequency of accidentally sticking oneself with the needle 
compared with other devices: 
- no accidental needle stick 
Evaluation of uniJectTM 
- easy to use 
- average 
Vaccinator's opinion about uniJectTM: 
- like it 
Students' opinion about uni~ect? 
- like it 
Disposal of uniJectTM using a cardboard container 
- yes 
Common disposal procedure of used needles and sharps 
- burned 
- buried 
- collected 
Opinion about the written instructions on how to use 
uniJectTM: 
- easy to understand 
- difficult to understand 
Opinion about the illustration in the instructions on how to use 
uniJectTM: 
- clear 
- not clear 
Suggestions to improve the instructions: 
- quite clear 
- adjust needle size 
- add color 
- no comments 
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Disposal of the used device was 
properly done as evident from the 
responses where 75% commonly burn the 
sharps disposal boxes, while the rest (25%) 
bury them. 
Close monitoring of the students 
did not report any adverse effects resulting 
from the immunization. 
CONCLUSION AND 
RECOMMENDATION 
Based on the results of the 
observation and interviews it is concluded 
that: 
1. There was sufficient comprehension of 
the training materials among the 
supervisors as well- as the vaccinators. 
Both the written instructions and the 
illustrations were clear. 
2. ~ n i ~ e c t ~ ~  is well accepted by the 
vaccinators for its practicality, ease of 
use, and less rigid cold chain 
requirement. Students had less fear 
toward the device, and therefore 
perceived the injection as less painful. 
Recommendations 
1. It may be worthwhile to include the 
activation procedure of u n i ~ e c t ~ ~  on the 
foil pouch. 
2. Several points that need closer attention 
and emphasis during the training: 
- Correct activation procedure of 
u n i ~ e c t ~ ~  
- How to properly squeeze the 
reservoir to obtain a correct dose 
- How to administer in'ection with 
attention on the UniJecjM's position 
and depth of needle. 
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